Lenalidomide and Dexamethasone Asymptomatic multiple Myeloma with high Risk of Disease Progression

被引：0
|
作者：
Ahlborn, M. [1 ]
机构：
[1] Stadt Klinikum Braunschweig, Med Klin 3, D-38114 Braunschweig, Germany
来源：
ONKOLOGE | 2013年 / 19卷 / 12期
关键词：
D O I：
10.1007/s00761-013-2591-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1076 / 1077
页数：2
相关论文
共 50 条
  • [41] CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE IN THE MANAGEMENT OF LENALIDOMIDE-REFRACTORY MULTIPLE MYELOMA
    Cerchione, C.
    Catalano, L.
    Nappi, D.
    Musuraca, G.
    Lucchesi, A.
    Pareto, A. E.
    Di Perna, M.
    Ferrara, K.
    Ronconi, S.
    Ceccolini, M.
    Cangini, D.
    Giannini, M. B.
    Di Battista, V.
    Simonetti, G.
    Ferrari, A.
    Bochicchio, M. T.
    di Rora, A. Ghelli Luserna
    Ghetti, M.
    Napolitano, R.
    Fontana, M. C.
    Padella, A.
    Pane, F.
    Martinelli, G.
    HAEMATOLOGICA, 2020, 105 : S104 - S104
  • [42] CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE IN THE MANAGEMENT OF LENALIDOMIDE-REFRACTORY MULTIPLE MYELOMA
    Cerchione, C.
    Martinelli, G.
    Nappi, D.
    Pareto, A. E.
    Di Perna, M.
    Ferrara, K.
    Musuraca, G.
    Lucchesi, A.
    Ferrari, A.
    Simonetti, G.
    Pane, F.
    Catalano, L.
    HAEMATOLOGICA, 2019, 104 : 71 - 71
  • [43] Carfilzomib-Lenalidomide-Dexamethasone in the Management of Lenalidomide-Refractory Multiple Myeloma
    Cerchione, Claudio
    Nappi, Davide
    Pareto, Anna Emanuele
    Pane, Fabrizio
    Catalano, Lucio
    Martinelli, Giovanni
    BLOOD, 2021, 138
  • [44] CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE IN THE MANAGEMENT OF LENALIDOMIDE-REFRACTORY MULTIPLE MYELOMA
    Cerchione, C.
    Ferrara, K.
    Peluso, I.
    Di Perna, M.
    Zacheo, I.
    Nappi, D.
    Pareto, A. E.
    Pane, F.
    Catalano, L.
    HAEMATOLOGICA, 2018, 103 : S85 - S85
  • [45] CARFILZOMIB AND LENALIDOMIDE AND DEXAMETHASONE VS LENALIDOMIDE AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA: TEMPORARY ANALYSIS OF RESPONSE TO THE HAZARD RATIO FOR PROGRESSION-FREE SURVIVAL
    Maria Victoria, Mateos Manteca
    Meletios, Dimopoulos A.
    Keith, Stewart A.
    Michael, Wang
    Vladimir, Maisnar
    Jiri, Minarik
    William, Bensinger, I
    Dina, Ben-Yehuda
    Vishal, Kukreti
    Mihaela, Obreja
    Sanjay, Aggarwal
    Philippe, Moreau
    Antonio, Palumbo
    HAEMATOLOGICA, 2016, 101 : 27 - 27
  • [46] Carfilzomib-Lenalidomide-Dexamethasone in the Management of Lenalidomide-Refractory Multiple Myeloma
    Cerchione, Claudio
    Catalano, Lucio
    Nappi, Davide
    Musuraca, Gerardo
    Lucchesi, Alessandro
    Pane, Fabrizio
    Martinelli, Giovanni
    BLOOD, 2020, 136
  • [47] Carfilzomib-lenalidomide-dexamethasone vs lenalidomide-dexamethasone in relapsed multiple myeloma by previous treatment
    Dimopoulos, M. A.
    Stewart, A. K.
    Masszi, T.
    Spicka, I.
    Oriol, A.
    Hajek, R.
    Rosinol, L.
    Siegel, D.
    Mihaylov, G. G.
    Goranova-Marinova, V.
    Rajnics, P.
    Suvorov, A.
    Niesvizky, R.
    Jakubowiak, A.
    San-Miguel, J.
    Ludwig, H.
    Ro, S.
    Aggarwal, S.
    Moreau, P.
    Palumbo, A.
    BLOOD CANCER JOURNAL, 2017, 7 : e554 - e554
  • [48] Carfilzomib and dexamethasone induction with lenalidomide, clarithromycin and dexamethasone consolidation and lenalidomide maintenance for newly diagnosed multiple myeloma
    Forsberg, Peter A.
    Rossi, Adriana C.
    Boyer, Angelique
    Pearse, Roger N.
    Pekle, Karen A.
    Jayabalan, David
    Lakritz, Stephanie
    Flicker, Kari
    Ribadeneyra, Drew
    Liotta, Brielle
    Ely, Scott
    Boussi, Leora
    Allan, John N.
    Coleman, Morton
    Niesvizky, Ruben
    Mark, Tomer M.
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (12) : 1554 - 1562
  • [49] A comparison of lenalidomide/dexamethasone versus cyclophosphamide/lenalidomide/dexamethasone versus cyclophosphamide/bortezomib/dexamethasone in newly diagnosed multiple myeloma
    Khan, Meaghan L.
    Reeder, Craig B.
    Kumar, Shaji K.
    Lacy, Marthy Q.
    Reece, Donna E.
    Dispenzieri, Angela
    Gertz, Morie A.
    Greipp, Phillip
    Hayman, Suzanne
    Zeldenhurst, Steven
    Dingli, David
    Lust, John
    Russell, Stephen
    Laumann, Kristina M.
    Mikhael, Joseph R.
    Bergsagel, P. Leif
    Fonseca, Rafael
    Rajkumar, S. Vincent
    Stewart, A. Keith
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 156 (03) : 326 - 333
  • [50] Carfilzomib, Lenalidomide, and Dexamethasone Followed by Lenalidomide Maintenance for Prevention of Symptomatic Multiple Myeloma in Patients With High-risk Smoldering Myeloma A Phase 2 Nonrandomized Controlled Trial
    Kazandjian, Dickran
    Hill, Elizabeth
    Dew, Alexander
    Morrison, Candis
    Roswarski, Joseph
    Korde, Neha
    Emanuel, Michael
    Petrosyan, Ani
    Bhutani, Manisha
    Calvo, Katherine R.
    Dulau-Florea, Alina
    Kwok, Mary
    Lee, Min-Jung
    Lee, Sunmin
    Lindenberg, Liza
    Mailankody, Sham
    Manasanch, Elisabet
    Maric, Irina
    Mena, Esther
    Patel, Nisha
    Tageja, Nishant
    Trepel, Jane B.
    Turkbey, Baris
    Wang, Hao-Wei
    Wang, Weixin
    Yuan, Constance
    Zhang, Yong
    Braylan, Raul
    Choyke, Peter
    Stetler-Stevenson, Maryalice
    Steinberg, Seth M.
    Figg, William D., Sr.
    Roschewski, Mark
    Landgren, Ola
    JAMA ONCOLOGY, 2021, 7 (11) : 1678 - 1685
12345